Added to YB: 2021-05-29
Pitch date: 2021-05-29
PIRS [bullish]
Pieris Pharmaceuticals, Inc.
-95.11%
current return
Author Info
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications.
Market Cap
$22.3M
Pitch Price
$278.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.16
P/E
-1.34
EV/Sales
2.17
Sector
Biotechnology
Category
growth
Show full summary:
PIRS Spells Potential
PIRS: Biotech w/ $8.8B potential milestone payments (32x mcap) + royalties from AZ, Seagen, Genentech deals for Anticalin drugs. Recent activity: AZ potential doubled to $5.4B, investments from AZ & Seagen. Upside if treatments work, but dilution risk. 10-20x+ long-term potential.
Read full article (3 min)